(PRWEB) August 28, 2013
Fueled in part by testimony given at two trials for DePuy ASR hip lawsuits, a group of attorneys has called for the U.S. Food and Drug Administration to investigate whether Johnson & Johnson subsidiary DePuy Orthopaedics withheld key risk data from regulators, according to court documents (In re: DePuy Orthopaedics Inc., ASR Hip Implant Products Liability Litigation, MDL-2197; U.S District Court for the Northern District of Ohio). The Rottenstein Law Group LLP, which maintains an ASR lawsuits information page at http://www.depuyhiprecallnewscenter.com/lawsuits, notes that the risks mentioned in the claims are typically those allegedly withheld.
The DePuy ASR and ASR XL hip replacement systems are “metal-on-metal” devices. One of the potentially dangerous adverse side effects of this composition is that the components can rub together, causing metal poisoning, or “metallosis,” according to the FDA.* That is, metal ions can flake off into the implantee’s bloodstream and cause neurological problems, among others.
“We applaud the attention the calls for investigation bring to information that has shown up in testimony during trial and in claims against DePuy, including lawsuits we have filed on behalf of those who allege their hip implant has harmed them,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP.
The attorneys allege that DePuy hid the metal poisoning risks, in addition to the defective nature of the hip device that results in patients needing painful revision surgery to fix the defect, according to court documents. The premature failure rate is disputed but has been said to be anywhere from 33 to 60 percent.
There are more than 11,000 DePuy ASR lawsuits pending in federal court alone, and DePuy recently was said to be mulling over settling the suits for about $3 billion, according to Bloomberg.** In 2010 Johnson & Johnson recalled 93,000 metal-on-metal hip implants worldwide, about 33,000 of those in the United States.
The Rottenstein Law Group LLP represents clients in ASR hip lawsuits. The firm encourages those who believe they have suffered from the ASR’s alleged side effects to visit the firm’s FAQ page to learn more about lawsuits and settlements.
About THE ROTTENSTEIN LAW GROUP LLP
The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)
The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com